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Glomerular  damage  constitutes  the  most  constant  and  one  of  the  most 
important  pathologic features  in  toxemia  of  pregnancy.  The  histologic  ab- 
normalities most  often described are  swelling  of glomerular  cells,  especially 
the endothelial cells  (1). Less commonly, more severe lesions are seen char- 
acterized by fibrinoid deposits  along  the basement membrane  (2),  or  fibrin 
thrombi within glomerular capillaries (3). In rare instances widespread glom- 
erular thrombosis and cortical necrosis develop; this picture is most often seen 
in cases complicated by abruptio placentae. 
In recent years the nature of the glomernlar abnormalities has been clarified 
by  electron microscopic studies.  The  characteristic findings  are marked  en- 
dothelial swelling, widening of intercapillary spaces,  and the frequent occur- 
rence of deposits along the basement membrane of dense,  granular material 
(2, 4-8). Such deposits are generally not visible by light microscopy. Similar 
glomerular lesions have been observed in  rabbits  in  which  a  state  of intra- 
vascular  coagulation  was  induced  (9).  The  glomerular  changes  ranged  in 
severity from those showing only endothelial and intercapillary cell swelling 
to  those  with  complete glomerular  thrombosis  and  cortical  necrosis.  All  of 
the lesions were shown to be the result of the arrest in glomeruli of some form 
of  circulating  fibrin.  These  observations  suggested  that  accelerated  intra- 
vascular fibrin formation might account not only for the severe renal lesions 
of pregnancy, but also for the abnormalities most commonly encountered in 
toxemia. 
The present study was undertaken to determine whether an abnormal con- 
centration of fibrin was present in the glomerular lesions of toxemia of preg- 
nancy. 
Materials and Methods 
Patients.--The patients were from the obstetrical service of Bellevue  Hospital (III Surgi- 
cal Division).  The diagnosis  of toxemia  was based on the development  of persistent proteinuria 
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and elevation of the blood pressure in the third trimester of pregnancy in the absence of evi- 
dence of urinary tract infection, previous hypertension, or renal disease. The patients who 
served  as  controls lacked  these  findings.  Proteinuria was  determined  qualitatively on  the 
first urine voided in the morning. The clinical findings are summarized in Tables I  and II. 
TABLE  I 
Toxemic Patients 
Time of biopsy 
A.P. 39 wks. 
A.P. 35 wks. 
P.P.  3 days 
A.P. 37 wks. 
A.P. 42 wks. 
A.P. 33 wks. 
A.P. 38 wks. H 
A.P. 33 wks. 
P.P.  7 days 
A.P. 28 wks. 
A.P. 25 wks. 
P.P.  1 day][ 
A.P. 36 wks. 
A.P. 30 wks.[I 
Pro- 
teinuria 
+ 
++ 
+ 
-++-~ 
+++ 
.++-f 
+++ 
++ 
++ 
+++ 
+++ 
Glomerular 
Blood  abnormalities 
pressure*  in histologic 
section 
130/90  f Present 
15o/100  § 
§ 
140/90  Equivocal 
140/9o  § 
lso/98  § 
Present 
1148/100  Present 
§ 
!144/96  Present 
1150/100  Present 
i40/ioo  § 
! 150/i00  Present 
~ 200/130  § 
Immtmofluorescent 
staining for 
ulln I  mm~  ~le 
+;+  o  oo 
+  0  0  0 
+  t  0  0  0 
/ 
+  [  o  o  o 
+++[  o  o  o 
+++  0  I +  0 
+++]  +  +  o 
+++  +  +  o 
+  ±  +  0 
+++  0  +  0 
+++  0  0  0 
++  0  0  0 
+++  +  +  0 
+++  0  J  0  0 
I 
A.P.,  antepartum;  P.P.,  postpartum. 
* Refers to highest blood pressure reading. 
:~ Refers to  droplets in glomerular epithelial ceils. 
§ Tissue not available for histologic sections. 
]] Stillborn. 
Processing of T/ssue.--Renal biopsy was performed percutaneously using a modified Frank- 
fin Vim  Silverman needle.  The biopsy specimen was  divided  into 2  pieces;  one piece was 
frozen and if it was found to contain giomeruli on frozen section, the other portion was fixed 
in Bouin's solution. The tissue fixed  in Bouin's for histological examination was  sectioned 
at 1 to 2 micra and stained with hematoxylin and  eosin, PAS, azancarmine, PAS silver me- 
thenamine,  and  phosphotungstic acid  hematoxylin (PTAH).  The  portion to be frozen was P. VASSALLI~  R. H. ~ORRIS~  AND  R. T. McCLUSKEY  469 
inserted into a small slit made in a block of fresh rabbit fiver and frozen by CO2 gas on a freez- 
ing stage. 
Specimens were sectioned immediately at 4 micra in an International-Harris cryostat and 
were stained the same day or were stored at --20°C until stained. It was found that storage 
under these conditions did not lead to appreciable loss of specific staining during a period of 
several weeks. Sections were fixed in acetone for 10  minutes and washed for 5  minutes in 
0.15  M saline containing 0.02  M phosphate buffer at pH 7.0. The sections were covered with 
TABLE II 
Contrd Patients 
Time of biopsy 
A.P. 37 wks. 
A.P. 35 wks. 
A.P. 38 wks. 
P.P. 4 days 
P.P. 3 days 
P.P. 4 days 
Clinical  data 
Normal preg- 
nancy 
Normal preg- 
nancy 
Urinary tract 
infection 
Urinary tract 
infection 
Probable hy- 
pertensive 
disease 
Normal preg- 
nancy 
Pathologic findings 
in histologic 
sections 
Absent 
Absent 
Focal lympho- 
cytic infiltra- 
tion 
Arteriolar 
changes com- 
patible with 
hypertensive 
disease 
InIIiluno- 
fluorescent 
staining for 
.y° 
Fi  n  Glob- 
ulln 
0 
0 
0 
0 
0 
0 
A.P., antepartum; P.P., postpartum. 
* Tissue  not  available for histologic section. 
the conjugated antiserum for 30 minutes in a moist chamber at room temperature, followed 
by 2 washes of 5 to 10 minutes in buffered saline. The tissues were examined by a Zeiss stand- 
ard microscope used with an Osram HBO 200-watt lamp and a darkfield immersion condensor. 
The frozen sections contained between 3 and 10 glomeruli. 
Antisera.--Antiserum  to  human  fibrinogen was  prepared by  immunizing rabbits  with 
human fraction I. The serum was repeatedly absorbed with human serum until it showed a 
single line by the Ouchterlouy method against human plasma and none against human serum. 
Rabbit  anti-human  ~-globulin  serum was obtained from Antibodies, Inc.  (Davis,  Cali- 
fornia). The antiserum was repeatedly absorbed by a  fraction of human serum from which 470  PATHOGENIC ROLE OF FIBRIN DEPOSITION 
v-giobulin had been removed by sodium sulfate precipitation. Following absorption the anti- 
serum produced a single line against human 7-globulin in double diffusion in agar and a char- 
acteristic -r-globulin line in immunoelectrophoresis. 
Rabbit anti-human albumin was obtained from Antibodies, Inc. By immunoelectrophoresis 
this serum showed a strong line against albumin and a very faint line against an a-globulin. 
Rabbit anti-human file and B1A was  generously provided by Dr.  Miiller-Eberhard  (10). 
This serum showed in immunoelectrophoresis a strong line against file and a faint line against 
~IA  • 
Conjugation.--The  antisera  were  conjugated  with  fluorescein  isothiocyanate on  Celite 
10 per cent (California Corp. for Biochemical Research,  Los Angeles) according to the method 
of Rinderknecht (11). Following conjugation the sera were  centrifuged for  30  minutes at 
15,000 RP,J at 5°C, and then dialyzed for several days at 4°C against 0.005 ~r phosphate buffer 
at pH 8.1. The background staining was of such low intensity that it was not necessary to 
remove non-specific  staining. The conjugated anti-Blc was shown to give definite but faint 
giomerular staining in several cases  of acute glomerulonephritis and lupus nephritis  (12). 
The specificity  of the fluorescent  staining for flbrinogen antigenic determinants was  shown 
by the complete abolition of staining by absorption of the conjugated serum with a  highly 
purified human fibrinogen kindly provided by Dr. Alan Johnson (13). The specificity  of the 
staining for -/-globulin was demonstrated by the complete removal of staining by absorption 
of the conjugated serum by human fraction II. 
RESULTS 
The pertinent clinical data  and  the  results  of histologic and immunofluorescent 
studies are shown in Tables I  and II. Of the biopsies from the toxemic patients, ma- 
terial from  7  was  processed  by regular  histologic methods.  In 6  of  these  patients, 
glomerular abnormalities were found and in the other only equivocal changes were 
present. The changes were not so distinctive as to be considered as diagnostic, but 
they resemble those previously described by others  (1). The glomeruli tended to fill 
Bowman's space,  the endothelial cells and intercapillary cells were swollen, and the 
capillary lumens narrowed (Fig. 1). Swelling of epithelial cells was also seen and these 
occasionally  contained  eosinophilic,  PAS-positive  droplets.  Equivocal  endothelial 
cell proliferation was present in 2 cases. In 2 cases PAS silver methenamine sections 
showed abundant finely fibrillar silver staining material in the intercapillary regions 
and between endothelial cells; in some areas the fibrils gave the appearance of dupli- 
cation of the basement membrane (Fig. 2).  In the 4  instances in which only frozen 
sections were available, evaluation of endothelial swelling was not possible. 
In none of the cases were severe changes encountered and in particular no glomerular 
thrombi, fibrinoid deposits,  or  deposits of material with  the  staining properties  of 
fibrin were seen. Sections from control patients showed no abnormalities, except for 
focal  interstitial lymphocytic infiltration in one  case,  and  arteriolar  thickening in 
another. 
In the sections exposed to conjugated anti-fibrin serum, bright staining of glomeruli 
was seen in all of the biopsies from patients with toxemia. Except in one case, all the 
glomeruli were stained to  a  fairly uniform extent. The  staining involved the entire 
glomernlus and appeared to be within endothelial cells and intercapillary cells (Figs. 
3 and 4). Occasionally, there was deposition of brightly staining material which ap- 
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within  glomerular  epithelial  cells,  although  the presence  of some material  in  this 
location could not be excluded. Fibrin thrombi were not identified within glomernlar 
capillaries.  In most cases, the glomerular staining was so bright  that  these structures 
stood out dearly at low magnification (about 32  X). The glomerular staining was 
arbitrarily graded as 1, 2, or 3+. In one case, a single glomerulus showed virtually no 
staining, whereas the others were brightly stained. In material from both control and 
toxemic groups, faint to moderate staining was seen in many intertubnlar capillaries. 
In two instances, repeat biopsies were performed postpartum, at 4 and 7 days, and 
it was found that the glomeruli still contained fibrin, although less than during preg- 
nancy. It is known from electron microscopic studies that the glomerular lesions only 
slowly involute following delivery (2). 
Biopsies were performed in 6 control patients. Three were done before ddivery and 
3 within 4 days following delivery. Only very faint glomerular staining was seen (Fig. 
5), which, however, was not present in tissue stained with conjugated antiserum pre- 
viously absorbed with human fibrinogen, indicating that small amounts of fibrinogen 
or fibrin were present within these glomeruli. 
Examination of the biopsies for 7-globulin showed significant  staining  in  only 3 
toxemic patients and in none of the controls. The 7-globulin was seen in the form of 
irregular deposits along the basement membrane (Fig. 6). Deposits of fibrin with the 
same distribution were seen in these cases.  In one instance, the 7-globulin was seen 
only in a repeat biopsy performed 3 weeks after the first, and the material was ir- 
regularly distributed among and within glomernli. In several cases in both groups there 
was observed a faint, very thin line of staining for 7-globulin apparently along the 
basement  membrane,  the  significance  of which  is  unknown. 
Biopsies were examined for albumin and/~10 only in the toxemic group. Sections 
stained for albumin failed to show staining in glomeruli except for 3 cases,  in which 
bright granules were seen in epithelial cells. In 3 cases with  marked  proteinuria,  nu- 
merous, brightly stained droplets were present within the cytoplasm of tubular cells. 
In sections  stained  for rio  no staining  was  observed. 
DISCUSSION 
In the present  study,  a  striking  concentration  of fibrin or other materials 
derived from fibrinogen  1 has been demonstrated by ilnmunofluorescence in the 
glolneruli of patients with toxemia of pregnancy. In contrast,  gamma globulin 
was only occasionally demonstrable and was present  in smaller  amounts and 
in a  different distribution, fllc,  a  constituent of complement, was not observed 
in glomeruli.  Albumin was only rarely seen, and then in the form of droplets 
within  epithelial  cells.  In pregnant patients  without  toxemia  only very faint 
stairdng for fibrin was observed in glomeruli. 
Fibrin  was  distributed fairly uniformly throughout  glolneruli  and  was de- 
posited  within  endothelial  and  intercapillary  cells;  swelling  of  these  cells 
*  For convenience, material stained by the anti-fibrin serum will  be referred to  as fibrin, 
although  it is most likely that  the stained  material  largely represents  some derivative  of 
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constituted the major pathologic change seen in histologic sections. The con- 
sistent presence of fibrin and its wide distribution in glomeruli indicate that 
the material  stained did not correspond  only to  the  abnormal deposits  fie- 
quently observed by electron microscopy in this condition. However, in three 
cases fibrin was observed not only diffusely within cells but also in the form of 
deposits which followed the basement membranes. 
The results of immunofluorescent staining of glomeruli in toxemia appear 
to be different from those observed in any other glomerular disease. Marked 
accumulation of fibrin may occasionally be demonstrated in glomeruli in acute 
glomerulonephritis, or lupus nephritis (12), but in these conditions the material 
is less regularly distributed within and among glomeruli. Furthermore, in these 
situations, striking accumulation of gamma globulin along the basement mem- 
brane is observed, as well as some rio. The absence of gamma globulin in glom- 
eruli  in most cases  of toxemia and  the  lack of complement provide  strong 
evidence against the suggestion that the glomerular lesions have an immunologic 
basis  (14).  The  significance of the  occasional presence  of irregular  deposits 
of gamma globulin is not clear, but they seem to be associated with unusually 
large deposits of fibrin along the basement membrane. It is possible that this 
represents trapping of gamma globulin in fibrin deposits. 
The  presence  of fibrin  within glomeruli has  been  reported  previously in 
certain complications of pregnancy. However, in contrast to  the present ob- 
servations,  such reports  have been  concerned with patients  with eclampsia, 
abruptio placentae, or with toxemia complicated by abruptio placentae, and 
the fibrin was apparent in histologic sections as intraluminal deposits. In these 
conditions, there is evidence for the existence of a state of intravascular clot- 
ting. In many cases, widespread deposits of fibrin have been observed within 
small vessels  of many organs, such as liver, lungs, adrenals, hypophysis, brain 
(3,  15,  16),  and particularly in glomeruli, where large occlusive fibrin masses 
are frequently associated with renal cortical necrosis (3). An immunofluorescent 
study of one such case has confirmed that the deposits are composed largely 
of fibrin (17). These conditions are often accompanied by a hemorrhagic state 
which is  characterized by depression of circulating fibrinogen, platelets, and 
other clotting factors and which is generally believed to  be due to  the  con- 
sumption of clotting factors resulting from extensive intravascular coagulation 
(15,  18,  19).  This is  sometimes associated  with an  excessive fibrinolytic re- 
sponse, in which case the hemorrhagic state is accentuated and the fibrin de- 
posits  may be prevented. It has been proposed that these complications are 
initiated by release  of thromboplastin secondary to  placental  abnormalities 
(15,  18). It is possible to extract from placental tissue a  thromboplastic ma- 
terial which, when injected into experimental animals, results in fibrin deposi- 
tion with hepatic lesions similar to those observed in eclampsia and in clotting 
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been demonstrated that intravenous injections of thrombin can also lead to 
renal cortical necrosis  (20,  21).  Evidence that renal cortical necrosis compli- 
cating pregnancy is  the  result of a  state of intravascular  clotting has been 
reviewed elsewhere (22).  The resemblance of the lesions of these severe com- 
plications  of  pregnancy  to  those  of  the  generalized  Shwartzman  reaction, 
which was pointed out by McKay (3),  can be understood in the light of the 
knowledge that this experimental disease is the consequence of intravascular 
coagulation (23). 
The clinical course and morphologic features of uncomplicated toxemia do 
not suggest that this condition has a  pathogenic mechanism similar to that 
responsible for the acute complications just discussed. However, the demon- 
stration in the preseilt study of large amounts of fibrin in glomeruli in toxemia 
provides a link between these conditions. 
It is proposed that the glomerular lesions of toxemia represent a reaction to 
some form of circulating fibrin which is arrested in glomeruli, and it is suggested 
that this could be the result of a prolonged state of slow intravascular coagula- 
tion. It has been shown experimentally that the infusion of thromboplastin 
into rabbits can result in glomerular lesions characterized ultrastructurally by 
endothelial  swelling and  deposits  similar  to  those  seen  in  toxemia  (9,  24). 
It was shown that the dense granular material forming these deposits, which 
is sometimes referred to as fibrinoid (2), was derived from fibrin and that the 
endothelial swelling was a  consequence of phagocytosis of fibrin. Endothelial 
swelling was sometimes observed even when fibrin or fibrinoid were not demon- 
strable  by electron microscopy, and evidence was presented indicating that 
this represented a reaction to ingestion of some form of fibrin precursor (9, 24). 
Shainoff and Page have recently shown that the fibrin monomer may combine 
with native fibrinogen to form a  complex referred  to  as  cryoprofibrin  (25). 
With slow  coagulation, this material may be formed in the absence of fully 
polymerized  fibrin  (25).  Cryoprofibrin  appears  in  the  circulation  when  in- 
travascular  coagulation  occurs  and  is  considered  to  be  the  most  sensitive 
indicator of the action of thrombin on fibrinogen in v/vo (26).  It appears that 
the material referred to as heparin-precipitable fibrinogen (27), which is present 
in the blood of rabbits perfused with thrombin (20),  represents cryoprofibrin 
(25, 26). Thus, with slow intravascular coagulation, cyroprofibrin and perhaps 
other abnormal complexes derived from fibrinogen are present in the circula- 
tion. 
It is known that glomerular damage can result from deposition of circulating 
colloidal material, and, in many such instances, no obvious pathologic changes 
are seen in other sites (28).  When colloidal material is present in the circula- 
tion, most of it is cleared by the reticuloendothelial system; these phagocytic 
cells quickly degrade the material, in most instances, without apparent damage. 
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rate but show progressive accumulation of such material, associated with the 
development of glomerular damage (29). Evidence that products derived from 
fibrinogen  in  the  course  of  intravascular  coagulation  are  removed  by  the 
reticuloendothelial system has  recently been  obtained  (30).  The  glomerular 
lesions of toxemia would appear to represent a reaction to circulating colloidal 
material derived from fibrinogen. 
Although no  conclusive  evidence  of  a  state  of  accelerated  intravascular 
clotting ill toxemia has been presented, several observations have been reported 
which can be interpreted in this way. These include prolongation of clotting 
time, thrombin time (31), and thrombocytopenia (31, 32), which is known to be 
a  sensitive indicator  of intravascular  clotting.  Of particular  interest  is  the 
observation of Smith that unusually high levels of heparin-precipitable fibrino- 
gen occur in toxemia of pregnancy (33). The consequence of slow intravascular 
clotting may be accentuated by impairment of fibrinolytic mechanisms, which 
is known to occur during pregnancy (34). 
That  toxemia  is  the  result  of  the  release  of  noxious  substances  from 
the placenta is an old and widely held concept. Excessive degenerative changes 
of the placenta have been described as characteristic of toxemia (35,  36).  It 
has been proposed  that these changes may be  responsible for the release of 
thromboplastic substances of the placenta, and that this could play a  role in 
the pathogenesis of toxemia (35, 37). It is possible that placental abnormalities 
could  result  in  the  prolonged  release  of smMl  amounts  of  thromboplastin. 
Thus, all of the complications of pregnancy which have been mentioned above 
may be due to intravascular coagulation resulting from placental abnormalities 
which occur at different levels of intensity and for different periods of time. 
Depending upon these factors, and on the fibrinolytic response,  there would 
result  a  whole  range  of glomerular lesions varying from simple  endothelial 
swelling to complete glomerular thrombosis, and a  variety of clinical states. 
It is not surprising that the acute complications occur with greater frequency 
in the face of previous placental damage associated with toxemia, nor, on the 
other hand, that such states could arise de novo  as  the result  of  some acute 
placental catastrophe. 
There  are  indications that even in  the course of normal pregnancy,  slow 
release of placental thromboplastin may occur at a low level. Peculiarities of the 
clotting system have been described, which have been referred to as a "hyper- 
coagulable  state"  (38),  and  elevations  of  heparin-precipitable  fibrinogen 
have been observed, but not to the levels seen in toxemia (33). In the present 
study, the impression was obtained that the glomeruli of patients with normal 
pregnancy showed an equivocal increase in fibrin as  compared with normal 
non-pregnant patients (12). 
The  glomerular  reaction  to  circulating  fibrin  could  explain  most  of  the 
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undoubtedly play a role in the toxemic state. Some of these may result from 
intravascular coagulation in ways other than an effect on glomeruli, for ex- 
ample by a release of vasoactive materials resulting from the action of thrombin 
on platelets (39) and fibrinogen (40). 
The demonstration, in the present study, of fibrin in glomeruli of patients 
with toxemia, the production of glomerular lesions resembling those seen in 
toxemia by thromboplastin infusions in rabbits, and the observations indicating 
dotting  abnormalities  in  toxemia,  provide  strong  evidence  that  the  basic 
pathogenic mechanism accounting for the renal lesions of toxemia is the re- 
action of the glomerulus to the arrest of some form of circulating fibrin. 
SUMMARY 
An immunofluorescent study of renal biopsies from patients with toxemia of 
pregnancy has been performed. It was found that the glomeruli consistently 
showed bright staining for fibrin within endothelial ceils, as well as occasional 
deposits along the basement membrane. Gamma globulin was only occasionally 
demonstrable, generally in the form of irregular deposits along the basement 
membrane.  /~1c was  absent  and  albumin was  not seen in  glomeruli,  except 
sometimes in the form of droplets within epithelial cells. 
In biopsies from pregnant patients without toxemia only equivocal staining 
for fibrin was seen. 
On the basis of these observations and other evidence discussed, it is pro- 
posed that the accumulation of fibrin in glomeruil reflects a prolonged state of 
intravascnlar  clotting in  toxemia and  that  the  arrest  in  glomeruli of some 
form of circulating fibrin constitutes the basic pathogenic mechanism of the 
glomerular damage in this disease. 
We wish to acknowledge the expert technical assistance of Miss Ened Foster. 
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EXPLANATION OF PLATES 
PLATE 45 
FIG. 1. Glomerulus from toxemic patient No. 7 showing swelling of ceils and  en- 
largement of the glomerulus. Hematoxylin and eosin.  X  700. 
Fie. 2. Portion of glomerulus from patient No. 5 shows increase in silver positive 
fibriUar material which produces apparent duplication of the basement membrane in 
one area. PAS silver methenamine.  X  2200. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  118  PLATE 45 
(Vassalli et al.: Pathogenic role of fibrin deposition) PLATE  46 
FIG.  3.  Biopsy  from  toxemic patient  No.  5  stained  with  anti-fibrin  serum.  Two 
brightly stained glomeruli are seen. The bright material  to  the  left of the lower glo- 
merulus represents blue autofluorescent material. The bright area to the leftof the upper 
glomerulus represents specific fluorescence  in the lumen of a small blood vessel.  X 360. 
FIG. 4.  Glomerulus from  toxemic patient No. 4 showing bright staining for fibrin 
within  swollen endothelial  and  intercapillary cells.  ×  700. THE  JOURNAL  OF EXPERIMENTAL  MEDICINE  VOL.  118  PLATE  46 
(Vassalli et al.: Pathogenic role of fibrin deposition) PLATE 47 
FIG. 5.  Glomerulus from control pregnant patient No.  12 showing extremely faint 
specific staining for fibrin in glomerulus. The bright granules outside the glomerulus 
are artefacts.  X  650. 
FIG. 6.  Glomerulus from toxemic patient No. 6 exhibiting moderately bright stain- 
ing for "F-globulin  in the form of deposits outlining basement membrane. This illus- 
trates the maximal amount of staining for "y-globulin which was seen. The thin line 
of specific staining seen throughout the glomerulus was also seen in normal glomeruli. 
X  1000. THE  JOURNAL  OF EXPERIMENTAL MEDICINE  VOL.  118  PLATE  47 
(Vassalli et al.: Pathogenic role of fibrin deposition) 